Skip to main content
Premium Trial:

Request an Annual Quote

Li-Cor Biosciences D-DiGit Gel Scanner

Li-Cor Biosciences has launched the LED-based D-DiGit Gel Scanner, designed to help researchers eliminate the risk of ethidium bromide exposure and workspace contamination from their nucleic acid gel analysis experiments. The new system enables safe and convenient detection of DNA and RNA samples stained with fluorescent safe stains, like SYBR Safe, which are sensitive and environmentally friendly alternatives to ethidium bromide. Added either during gel preparation, or as a post-electrophoresis stain, safe stains eliminate the need for hazardous disposal and hassles associated with ethidium bromide. The D-DiGit improves protocol efficiency by consolidating nucleic acid analysis on a single system dedicated to high-sensitivity gel imaging. The scanner provides a large scan area to visualize most medium and larger format gels. Nucleic acid band extraction and imaging can be performed directly on the scan surface, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.